التفاصيل البيبلوغرافية
العنوان: |
Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2. |
المؤلفون: |
Xiao, Cheng, Ling, Shiman, Qiu, Minshan, Deng, Zhenxuan, Chen, Liping, Zhu, Airu, Chen, Yi, Liu, Yong, Lin, Xia, Lin, Fangmei, Wu, Qiubao, Shen, Lihan, Ye, Feng, Liu, Xiaoqing, Li, Yimin, Zhao, Jincun, Yang, Zifeng, Cowling, Benjamin J., Webby, Richard, Zanin, Mark |
المصدر: |
Influenza & Other Respiratory Viruses; Jan2021, Vol. 15 Issue 1, p7-12, 6p |
مصطلحات موضوعية: |
SARS-CoV-2, VIRAL proteins, COVID-19, COVID-19 testing, PROTEINS |
مستخلص: |
To inform seroepidemiological studies, we characterized the IgG‐ responses in COVID‐19 patients against the two major SARS‐CoV‐2 viral proteins, spike (S) and nucleocapsid (N). We tested 70 COVID‐19 sera collected up to 85 days post‐symptom onset and 230 non‐COVID‐19 sera, including 27 SARS sera from 2003. Although the average SARS‐CoV‐2 S and N‐IgG titers were comparable, N‐responses were more variable among individuals. S‐ and N‐assay specificity tested with non‐COVID‐19 sera were comparable at 97.5% and 97.0%, respectively. Therefore, S will make a better target due to its lower cross‐reactive potential and its' more consistent frequency of detection compared to N. [ABSTRACT FROM AUTHOR] |
|
Copyright of Influenza & Other Respiratory Viruses is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |